The outcomes of this study support the use of high PD-L1 expression on ICs in conjunction with increased TIL density as prognostic markers of the survival rates of HNSCC patients undergoing definitive radiotherapy and/or radiochemotherapy. This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.